| Serial Number | 98602433 |
| Word Mark | BEMTUVIK |
| Filing Date | Friday, June 14, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Friday, September 6, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of gastric and gastro-esophageal diseases, conditions or maladies; other pharmaceutical preparations |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 14, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Amgen Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Thousand Oaks, CA 91320-1799 |
| Event Date | Event Description |
| Friday, June 14, 2024 | NEW APPLICATION ENTERED |
| Friday, September 6, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, September 6, 2024 | ASSIGNED TO EXAMINER |
| Friday, June 14, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, September 6, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, September 6, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, September 17, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Tuesday, September 17, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |